Akhtar Ahmed, senior secretary of the Election Commission (EC), said that the European Union (EU) has emphasized the need to ...

AMM Nasir Uddin on Tuesday said the European Union (EU) has put emphasis on reform and assured all sorts of assistance ahead ...

Despite the regulatory setback, BioArctic's partner Eisai has stated that the safety profile of lecanemab reported in clinical practice in the United States, Japan, and other countries is consistent ...

The European Commission has published on the 29th January the “Competitiveness Compass for the EU”, setting out ambitious initiatives aimed ...

The European Union's upcoming Digital Fairness Act has the potential to end exploitative practices online and enhance ...

The European Commission said on Friday that it has launched infringement procedures against Bulgaria for failing to fully ...

Merck (MRK) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, recommended ...

Unife has warned that EU member states are at risk of losing funding for vital rail schemes promised in the EU's Recovery and ...

Biogen (BIIB) and Eisai announced an update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab as ...

Biogen (BIIB) stock in focus as company and partner Eisai (ESALF) face delay in the EU launch of Alzheimer's drug lecanemab.

Google is squaring off against regulators from the European Commissions today in the EU Court of Justice in Luxembourg.

Projects will contribute to the European Union’s 2030 target of 50 million tpa of CO2 injection capacity as bloc pushes to ...